Possible scenario
Developer Adoption Builds
42% Chance
The $6,500 price point makes Dex5-S attractive to universities, robotics startups, and Chinese industrial labs that previously viewed dexterous hands as too expensive. This scenario is most likely because the product directly addresses the cost bottleneck highlighted in 2025, while still fitting Unitree's own caution that full humanoid deployment remains task-limited.
Secondary impacts
- Industrials +0.2%
- Technology +0.2%
Portfolio impact
S&P 500+0.1%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.